Français
- 01
Eli Lilly and Company
LLYNew York
$1.1 Billions
+4.4% 1W·+56.6% 1Y
- 02
Johnson & Johnson (J&J)
JNJNew York
$616 Milliards
+5.7% 1W·+32.3% 1Y
- 03
AbbVie Inc.
ABBVNew York
$504 Milliards
+0.6% 1W·+24.3% 1Y
- 04
F. Hoffmann-La Roche AG
ROGSIX Suisse
$372 Milliards
-6.5% 1W·— 1Y
- 05
Merck & Co., Inc.
MRKNew York
$360 Milliards
+1.4% 1W·+72.1% 1Y
- 06
Novartis AG
NOVNSIX Suisse
$286 Milliards
+2.4% 1W·+14.6% 1Y
- 07
AstraZeneca PLC
AZNNew York
$257 Milliards
+3.5% 1W·-3.2% 1Y
- 08
Novo Nordisk A/S
NVONew York
$170 Milliards
+0.5% 1W·-24.5% 1Y
- 09
Pfizer Inc.
PFENew York
$169 Milliards
+3.3% 1W·— 1Y
- 10
Bristol-Myers Squibb Company (BMS)
BMYNew York
$122 Milliards
+4.0% 1W·+37.0% 1Y
- 11
Sanofi S.A.
SNYNew York
$97.3 Milliards
+2.4% 1W·-19.8% 1Y
- 12
Sinopharm Group
01099Hong Kong
$6.2 Milliards
-1.5% 1W·— 1Y
Affichage de 1–12 sur 12